Pancreatic cancer - lessons from the past decade
- PMID: 26157280
- PMCID: PMC4477379
- DOI: 10.4103/0971-5851.158821
Pancreatic cancer - lessons from the past decade
Conflict of interest statement
References
-
- Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin. 2014;64:9–29. - PubMed
-
- Bauer TM, El-Rayes BF, Li X, Hammad N, Philip PA, Shields AF, et al. Carbohydrate antigen 19-9 is a prognostic and predictive biomarker in patients with advanced pancreatic cancer who receive gemcitabine-containing chemotherapy: A pooled analysis of 6 prospective trials. Cancer. 2013;119:285–92. - PMC - PubMed
-
- Hartwig W, Hackert T, Hinz U, Hassenpflug M, Strobel O, Büchler MW, et al. Multivisceral resection for pancreatic malignancies: Risk-analysis and long-term outcome. Ann Surg. 2009;250:81–7. - PubMed
-
- Riediger H, Makowiec F, Fischer E, Adam U, Hopt UT. Postoperative morbidity and long-term survival after pancreaticoduodenectomy with superior mesenterico-portal vein resection. J Gastrointest Surg. 2006;10:1106–15. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
